WS #16688
The AI trade is facing significant headwinds as Anthropic reported a staggering $23.29 billion net loss and $895.4 billion in aggregate committed spend, raising questions about the sustainability of frontier model development. This financial reality is compounded by Oracle's $20 billion capital raise and new Chinese AI export controls, signaling that the sector is hitting both financial and regulatory walls. While Microsoft continues to show strong Azure growth, the broader market is rotating out of speculative AI infrastructure into more established, cash-generating technology firms. A wave of analyst downgrades and target cuts is sweeping across sectors, with JPMorgan lowering Coherent's target to $385, Freedom Broker cutting Freeport-McMoRan's target to $68, and Ark Invest trimming Eli Lilly holdings. These moves signal a broad-based reassessment of growth valuations and commodity exposure in a risk-off environment. The concentration of downgrades in semiconductors, mining, and healthcare suggests that investors are actively de-risking portfolios and moving away from high-multiple assets.
AI Trade Headwinds and Capital Constraints
The AI trade is facing significant headwinds as Anthropic reported a staggering $23.29 billion net loss and $895.4 billion in aggregate committed spend, raising questions about the sustainability of frontier model development. This financial reality is compounded by Oracle's $20 billion capital raise and new Chinese AI export controls, signaling that the sector is hitting both financial and regulatory walls. While Microsoft continues to show strong Azure growth, the broader market is rotating out of speculative AI infrastructure into more established, cash-generating technology firms.
A wave of analyst downgrades and target cuts is sweeping across sectors, with JPMorgan lowering Coherent's target to $385, Freedom Broker cutting Freeport-McMoRan's target to $68, and Ark Invest trimming Eli Lilly holdings. These moves signal a broad-based reassessment of growth valuations and commodity exposure in a risk-off environment. The concentration of downgrades in semiconductors, mining, and healthcare suggests that investors are actively de-risking portfolios and moving away from high-multiple assets.